Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125535891 | 12553589 | 1 | I | 20160630 | 20160713 | 20160713 | EXP | DE-WATSON-2016-14606 | WATSON | STETTNER M, STEINBERGER D, HARTMANN CJ, PABST T, KONTA L, HARTUNG HP ET AL. ISONIAZID-INDUCED POLYNEUROPATHY IN A TUBERCULOSIS PATIENT - IMPLICATION FOR INDIVIDUAL RISK STRATIFICATION WITH GENOTYPING?. BRAIN BEHAV. 2015;5(8):E00326. | 23.00 | YR | M | Y | 0.00000 | 20160713 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125535891 | 12553589 | 1 | PS | ISONIAZID. | ISONIAZID | 1 | Unknown | UNKNOWN | UNCONFIRMED | 80521 | UNK | ||||||||
| 125535891 | 12553589 | 2 | SS | Linezolid (Unknown) | LINEZOLID | 1 | Unknown | UNKNOWN | UNCONFIRMED | 0 | UNK | ||||||||
| 125535891 | 12553589 | 3 | C | ETHAMBUTOL | ETHAMBUTOL HYDROCHLORIDE | 1 | Unknown | UNKNOWN | 0 | ||||||||||
| 125535891 | 12553589 | 4 | C | RIFAMPICIN | RIFAMPIN | 1 | Unknown | UNKNOWN | U | 0 | |||||||||
| 125535891 | 12553589 | 5 | C | PYRAZINAMIDE. | PYRAZINAMIDE | 1 | Unknown | UNKNOWN | U | 0 | |||||||||
| 125535891 | 12553589 | 6 | C | STREPTOMYCIN | STREPTOMYCINSTREPTOMYCIN SULFATE | 1 | Unknown | UNKNOWN | U | 0 | |||||||||
| 125535891 | 12553589 | 7 | C | PYRIDOXINE | PYRIDOXINE | 1 | Unknown | UNKNOWN | U | 0 | |||||||||
| 125535891 | 12553589 | 8 | C | CAPREOMYCIN | CAPREOMYCIN | 1 | Unknown | UNKNOWN | U | 0 | |||||||||
| 125535891 | 12553589 | 9 | C | MOXIFLOXACIN. | MOXIFLOXACIN | 1 | Unknown | UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125535891 | 12553589 | 1 | Tuberculosis |
| 125535891 | 12553589 | 2 | Tuberculosis |
| 125535891 | 12553589 | 3 | Tuberculosis |
| 125535891 | 12553589 | 4 | Tuberculosis |
| 125535891 | 12553589 | 5 | Tuberculosis |
| 125535891 | 12553589 | 6 | Tuberculosis |
| 125535891 | 12553589 | 7 | Supplementation therapy |
| 125535891 | 12553589 | 8 | Tuberculosis |
| 125535891 | 12553589 | 9 | Tuberculosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125535891 | 12553589 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125535891 | 12553589 | Blood creatinine increased | |
| 125535891 | 12553589 | Hepatic enzyme increased | |
| 125535891 | 12553589 | Polyneuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |